Neurovascular Devices Market Leads from North America in 2025!
In 2025, Neurovascular Devices Market commanding 28%! North America held the largest market. 🔍 Why is North America Dominating? Let’s […]
Metagenomic Sequencing Market Companies: Shaping the Landscape
The global metagenomic sequencing market is undergoing a significant transformation fueled by advances in genomics, increasing infectious disease prevalence, and
Life Science Products Market Companies (2024-2034)
The global life science products market is witnessing robust growth due to continuous innovation in biotechnology, diagnostics, and pharmaceutical R&D.
Compounding Chemotherapy Market Companies Driving Growth in the Global
The global Compounding Chemotherapy Market is on a steady rise, valued at USD 5.34 billion in 2024 and expected to
Life Science Logistics Market Companies Transforming Global Supply Chains in 2025
The global life science logistics market is witnessing a significant transformation with increasing demand for the safe and timely delivery
Life Sciences IT Market Companies Growth in 2025 and Beyond
The global Life Sciences IT market is undergoing a transformative shift, driven by digitization in healthcare and pharmaceutical sectors. With
AusperBio Secures China CDE Approval to Advance AHB-137 into Phase 3 Clinical Trial for Chronic Hepatitis B
July 2025Â Beijing, China: AusperBio Therapeutics Inc. and Ausper Biopharma Co., Ltd. (collectively known as AusperBio) have received the green
AstraZeneca Unveils $50 Billion Investment Plan to Supercharge U.S. Pharma Innovation by 2030
Virginia to host AstraZeneca’s largest-ever global manufacturing site, with AI-driven production and next-gen therapies July 2025 – USA: Global biopharma
Sarepta Therapeutics Temporarily Halts ELEVIDYS Shipments in U.S. Amid FDA Labeling Updates
Cambridge, MAÂ July 22, 2025: Sarepta Therapeutics, a leader in precision genetic medicine for rare diseases, has voluntarily paused all
Cycle Pharmaceuticals and Handa Therapeutics Forge Strategic Partnership to Launch PHYRAGO for Leukemia Patients in the U.S.
In a major stride towards revolutionizing leukemia treatment in the U.S., Cycle Pharmaceuticals has signed an exclusive sales license agreement